GST changes will take effect from next fiscal year
In short
GST law and rule changes will start from the next fiscal year. The source summary says the change is delayed until then.
This matters for pharma companies and tax planning, but the available reporting does not spell out the full rule change or which products are covered.
What the reporting says
GST law and rule changes will become effective from the next fiscal year, according to the publisher-supplied summary. The source snippet does not specify the exact GST Council decision, the affected pharmaceutical items, or the tax treatment details beyond the timing. The immediate consequence is delayed implementation, while the full scope of the changes remains unstated in the available reporting.
Why it matters
GST law and rule changes will become effective from the next fiscal year, according to the available summary. The reporting does not confirm the detailed mechanism or the specific pharma goods affected, beyond indicating a future implementation date. This could affect compliance and input tax credit treatment for companies in the sector once the rules begin.